Dynamic hyperinflammatory response assessment using HIC scores in COVID-19: application to a large series of patients receiving anakinra - Takeaways - MDSpire

Dynamic hyperinflammatory response assessment using HIC scores in COVID-19: application to a large series of patients receiving anakinra

  • By

  • Shirkhan Amikishiyev

  • Rabia Deniz

  • Mehmet Guven Gunver

  • Sarvan Aghamuradov

  • Nevzat Koca

  • Burak Ince

  • Murat Bektas

  • Aysenur Yilmaz

  • Yagmur Canturk

  • Gorkem Durak

  • Murat Kose

  • Mustafa Erelel

  • Arif Atahan Çağatay

  • Serap Simsek Yavuz

  • Sevgi Kalayoglu Besisik

  • Figen Esen

  • Ahmet Gül

  • May 22, 2026

  • 0 min

Share

  • 1

    The study analyzed 218 hospitalized COVID-19 patients with hyperinflammation treated with anakinra, focusing on mortality and inflammatory markers.

  • 2

    Overall in-hospital mortality was 12.8%, with survivors showing earlier CRP reduction compared to non-survivors.

  • 3

    Divergence in HIC scores and inflammatory parameters was observed within 3–4 days of anakinra treatment.

  • 4

    ROC analysis indicated that HIC scores at treatment initiation and final assessment effectively discriminated between survivors and non-survivors.

  • 5

    The findings support the HIC score as a dynamic monitoring tool for treatment response during IL-1 blockade in COVID-19.

Original Source(s)

Related Content